NEROFE

· Immune System Key Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NEROFE, covering 2018-06-25 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors [Phase 1]